Back
Ascendis Pharma AS Stock Predictions
Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
30
ASND
Ascendis Pharma AS
Last Price:
$159.41
Seasonality Move:
2.56%
7 Day Trial
ALL ACCESS PASS
$
7
Invest Where Innovation Meets Real Demand
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Ascendis Pharma AS Stock Forecast
-
Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 34.4% based on the past 10 years of stock performance.
-
Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Ascendis Pharma AS Stock Undervalued?The current Ascendis Pharma AS [ASND] share price is $157.27. The Score for ASND is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Ascendis Pharma AS Stock Go Up Next Year?
-
Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 34.4% based on the past 10 years of stock performance.
Ascendis Pharma AS Stock Rating
Sell
30
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS overpriced?
-
Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Ascendis Pharma AS Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com
52-Week Data
52-Week High:
183.00
52-Week Low:
111.09
Prediction Charts
Market Cap:
9.5B
Price in USD:
157.27
Volume:
370.1K
Beta:
0.61
Technical Analysis
SMA50:
158.41
SMA100:
148.30
SMA200:
140.47
52-Wk Change:
20.6%
Stock Predictions
-
Is Ascendis Pharma AS stock public?Yes, Ascendis Pharma AS is a publicly traded company.
-
What is the Ascendis Pharma AS stock quote today?The Ascendis Pharma AS stock price is 157.27 USD today.
-
How to buy Ascendis Pharma AS stock online?You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-7 | 162.31 | 160.99 | 164.81 | 160.01 |
| May-8 | 161.10 | 159.39 | 162.71 | 156.02 |
| May-9 | 159.45 | 151.25 | 161.39 | 151.11 |
| May-12 | 153.41 | 154.43 | 158.33 | 152.45 |
| May-13 | 155.20 | 161.52 | 162.30 | 154.64 |
| May-14 | 161.78 | 157.20 | 165.26 | 156.28 |
| May-15 | 157.14 | 157.54 | 159.03 | 150.89 |
| May-16 | 155.01 | 157.60 | 160.56 | 154.80 |
| May-19 | 157.00 | 160.33 | 160.38 | 156.46 |
| May-20 | 160.34 | 161.57 | 162.22 | 157.70 |
| May-21 | 160.38 | 158.10 | 162.38 | 157.02 |
| May-22 | 157.97 | 160.05 | 161.79 | 156.10 |
| May-23 | 157.77 | 162.00 | 162.12 | 153.49 |
| May-27 | 163.55 | 157.27 | 163.55 | 156.83 |
Ascendis Pharma AS Earnings
Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ascendis Pharma AS Forecast Revenue Growth
Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.